企業プロフィール
Aldeyra Therapeutics, Inc. 株価・ニュース・カタリスト
- ティッカー:
- ALDX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.56 USD (0.00%)
終値
最終更新: 2026年8月17日
98.9M USD
時価総額
株価変動の要因
As of Aug 17, 2026, ALDX was little changed and closed at $1.56. No new same-company headline was identified in the current news window.
企業概要
事業概要
Aldeyra Therapeutics is a biotechnology company focused on inflammation, ophthalmology, and immune-mediated disease. Its story is built around therapies for conditions where inflammation plays a major role.
所在地とセクター分類
Aldeyra is headquartered in the United States and listed on NASDAQ. It sits in specialty immunology and ophthalmology biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, regulatory progress, and the ability to develop a focused pipeline in challenging inflammatory diseases. Investors usually watch efficacy, safety, and approval milestones.
バイオ業界での位置付け
Aldeyra occupies a niche inflammation-and-eye-disease position within biotech. The stock is catalyst-sensitive because a narrow number of data events can meaningfully shift the story.
今後のカタリスト
- Aldeyra’s catalysts are reproxalap and the dry-eye / ophthalmology regulatory path, where the next step can materially move the stock. The company is still very event-driven.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。